ETABLISSEMENT FRANÇAIS DU SANG
54
Description
EFS – Etablissement Français du Sang (French Blood Establishment), a key player in the French healthcare system and the sole public operator of blood transfusion services, is fully committed to the bioproduction of innovative therapeutic drugs. Through its pharmaceutical platforms located throughout France, EFS Bioproduction supports the development and production of cell therapies. This expertise extends to several types of cells, such as MSCs, CAR-Ts, iPSCs, hESCs, and HSCs.
This unique know-how is based on solid scientific, technical, and regulatory expertise, as well as close collaboration with university researchers, clinicians, and industrial partners. EFS Bioproduction supports the development, industrialization, and production, in accordance with good manufacturing practices (GMP), of projects in preclinical and clinical phases, providing promising therapeutic solutions for patients with no alternative treatments.
Come meet our teams at booth 54 and let's build your innovative therapy drug bioproduction projects together!